While reaction to today's announcement may seem muted, there was always going to be a pull back in the shareprice.
Nothing to be concerned about at all, Azer-cel is wonderful technology and a game changer in anyone's language, but I still see Oncarlytics as the family jewel here.
Every other Car-T manufacturer is going to need this or another CD19 targeted technology to get into the solid tumours market, if they aren't, then their profits are going to be hugely under threat.
Whatever the next six months brings, Imugene shareholders are in for one hell of a ride.
DYOR opinion only
- Forums
- ASX - By Stock
- IMU
- Ann: Azer-cel Hits Major Milestone in Phase 1b CAR T Trial
Ann: Azer-cel Hits Major Milestone in Phase 1b CAR T Trial, page-155
-
- There are more pages in this discussion • 88 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $364.4M |
Open | High | Low | Value | Volume |
4.9¢ | 5.0¢ | 4.8¢ | $555.4K | 11.34M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
118 | 16458707 | 4.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.0¢ | 1728214 | 12 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
116 | 16443645 | 0.048 |
70 | 6992075 | 0.047 |
37 | 4755253 | 0.046 |
52 | 5221184 | 0.045 |
12 | 1153236 | 0.044 |
Price($) | Vol. | No. |
---|---|---|
0.050 | 1728214 | 12 |
0.051 | 1576328 | 10 |
0.052 | 1753192 | 11 |
0.053 | 1774938 | 12 |
0.054 | 2922460 | 12 |
Last trade - 16.10pm 21/10/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, Chief Executive Officer
Paul Long
Chief Executive Officer
SPONSORED BY The Market Online